Japan considers adjusting clinical trial requirements to remove the need for local studies — report
Japan is rethinking its clinical trial requirements to address a lag in Japanese approvals for new drugs that are already available in other countries, according …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
